134 related articles for article (PubMed ID: 73397)
1. Serum dihydrotestosterone in patients with benign prostatic hypertrophy.
Ghanadian R; Lewis JG; Chisholm GD; O'Donoghue EP
Br J Urol; 1977 Nov; 49(6):541-4. PubMed ID: 73397
[TBL] [Abstract][Full Text] [Related]
2. Total and SHBG-bound testosterone and 5 alpha-dihydrotestosterone serum concentrations in normal elderly men and patients with benign prostatic hypertrophy before and after removal of the adenoma.
Lukkarinen O
Br J Urol; 1980 Oct; 52(5):377-80. PubMed ID: 6159037
[TBL] [Abstract][Full Text] [Related]
3. Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate.
Drafta D; Proca E; Zamfir V; Schindler AE; Neacşu E; Stroe E
J Steroid Biochem; 1982 Dec; 17(6):689-93. PubMed ID: 6184548
[TBL] [Abstract][Full Text] [Related]
4. Responses of serum levels of testicular steroid hormones to hCG stimulation in patients with prostatic cancer and benign prostatic hypertrophy.
Isurugi K; Kanazawa M; Yanaihara T; Kambegawa A
Prostate Suppl; 1981; 1():19-26. PubMed ID: 6176980
[TBL] [Abstract][Full Text] [Related]
5. High serum dihydrotestosterone examined by ultrasensitive LC-MS/MS as a predictor of benign prostatic hyperplasia or Gleason score 6 cancer in men with prostate-specific antigen levels of 3-10 ng/mL.
Miyoshi Y; Uemura H; Suzuki K; Shibata Y; Honma S; Harada M; Kubota Y
Andrology; 2017 Mar; 5(2):262-267. PubMed ID: 27813361
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of 3H-testosterone and 3H-dihydrotestosterone metabolism in patients with benign prostatic hypertrophy. Effect of cyproterone acetate.
Hutschenreiter G; Sinterhauf K; Altwein JE
Eur Urol; 1977; 3(2):100-4. PubMed ID: 67948
[TBL] [Abstract][Full Text] [Related]
7. Suppressive effects of surgical stress on circulating androgens during and after prostatectomy.
Ghanadian R; Puah CM; Williams G; Shah PJ; McWhinney N
Br J Urol; 1981 Apr; 53(2):147-9. PubMed ID: 6165423
[TBL] [Abstract][Full Text] [Related]
8. Serum testosterone and dihydrotestosterone in carcinoma of the prostate.
Ghanadian R; Puah CM; O'Donoghue EP
Br J Cancer; 1979 Jun; 39(6):696-9. PubMed ID: 444409
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of serum dihydrotestosterone and subsequent risk of benign prostatic hyperplasia in community dwelling men: the Rancho Bernardo Study.
Parsons JK; Palazzi-Churas K; Bergstrom J; Barrett-Connor E
J Urol; 2010 Sep; 184(3):1040-4. PubMed ID: 20643424
[TBL] [Abstract][Full Text] [Related]
10. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer.
Rittmaster R; Hahn RG; Ray P; Shannon JB; Wurzel R
Urology; 2008 Oct; 72(4):808-12. PubMed ID: 18718641
[TBL] [Abstract][Full Text] [Related]
11. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D
Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
[TBL] [Abstract][Full Text] [Related]
12. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Bartsch G; Rittmaster RS; Klocker H
Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
[TBL] [Abstract][Full Text] [Related]
13. Measurements of prolactin and androgens in patients with prostatic diseases.
Saroff J; Kirdani RY; Chu TM; Wajsman Z; Murphy GP
Oncology; 1980; 37(1):46-52. PubMed ID: 6153126
[TBL] [Abstract][Full Text] [Related]
14. Serum of patients with prostatic cancer or benign prostatic hypertrophy contains nonpolar testosterone.
Addo SB; Holland JF; Kirschenbaum A; Mandeli J; Hollander VP
Steroids; 1990 Nov; 55(11):491-4. PubMed ID: 1706116
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial.
Idan A; Griffiths KA; Harwood DT; Seibel MJ; Turner L; Conway AJ; Handelsman DJ
Ann Intern Med; 2010 Nov; 153(10):621-32. PubMed ID: 21079217
[TBL] [Abstract][Full Text] [Related]
16. Secretion of dihydrotestosterone by human prostate in benign prostatic hypertrophy.
Mahoudeau JA; Delassalle A; Bricaire H
Acta Endocrinol (Copenh); 1974 Oct; 77(2):401-7. PubMed ID: 4138446
[No Abstract] [Full Text] [Related]
17. The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia.
Wurzel R; Ray P; Major-Walker K; Shannon J; Rittmaster R
Prostate Cancer Prostatic Dis; 2007; 10(2):149-54. PubMed ID: 17189955
[TBL] [Abstract][Full Text] [Related]
18. Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate.
Habib FK; Lee IR; Stitch SR; Smith PH
J Endocrinol; 1976 Oct; 71(1):99-107. PubMed ID: 62008
[TBL] [Abstract][Full Text] [Related]
19. Significant association between serum dihydrotestosterone level and prostate volume among Taiwanese men aged 40-79 years.
Liao CH; Li HY; Chung SD; Chiang HS; Yu HJ
Aging Male; 2012 Mar; 15(1):28-33. PubMed ID: 21247242
[TBL] [Abstract][Full Text] [Related]
20. [The influence of spironolactone on the concentration of gonadotrophins and gonadal hormones in prostatic hypertrophy (author's transl)].
Zgliczynski S; Baranowska B; Szymanowski J
J Urol (Paris); 1981; 87(9):635-8. PubMed ID: 6174646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
